{"id":"https://openalex.org/W2584534704","doi":"https://doi.org/10.1158/1078-0432.ccr-16-1990","title":"Correlation between Ferumoxytol Uptake in Tumor Lesions by MRI and Response to Nanoliposomal Irinotecan in Patients with Advanced Solid Tumors: A Pilot Study","display_name":"Correlation between Ferumoxytol Uptake in Tumor Lesions by MRI and Response to Nanoliposomal Irinotecan in Patients with Advanced Solid Tumors: A Pilot Study","publication_year":2017,"publication_date":"2017-02-03","ids":{"openalex":"https://openalex.org/W2584534704","doi":"https://doi.org/10.1158/1078-0432.ccr-16-1990","mag":"2584534704","pmid":"https://pubmed.ncbi.nlm.nih.gov/28159813"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-16-1990","doi":"https://doi.org/10.1158/1078-0432.ccr-16-1990","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-16-1990","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113733729","display_name":"Ramesh K. Ramanathan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1284308235","display_name":"Translational Genomics Research Institute","ror":"https://ror.org/02hfpnk21","country_code":"US","type":"facility","lineage":["https://openalex.org/I1284308235"]},{"id":"https://openalex.org/I4210130412","display_name":"HonorHealth","ror":"https://ror.org/03szbwj17","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210130412"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ramesh K. Ramanathan","raw_affiliation_strings":["1Virginia G Piper Cancer Center, Honor Healthcare, Scottsdale, Arizona","2Translational Genomics Research Institute, Phoenix, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Virginia G Piper Cancer Center, Honor Healthcare, Scottsdale, Arizona","institution_ids":["https://openalex.org/I4210130412"]},{"raw_affiliation_string":"2Translational Genomics Research Institute, Phoenix, Arizona","institution_ids":["https://openalex.org/I1284308235"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004915418","display_name":"Ronald Lee Korn","orcid":"https://orcid.org/0000-0003-1141-5749","observed_orcids":["https://orcid.org/0000-0003-1141-5749"]},"institutions":[{"id":"https://openalex.org/I4210130412","display_name":"HonorHealth","ror":"https://ror.org/03szbwj17","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210130412"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronald L. Korn","raw_affiliation_strings":["1Virginia G Piper Cancer Center, Honor Healthcare, Scottsdale, Arizona","3Imaging Endpoints, Scottsdale, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Virginia G Piper Cancer Center, Honor Healthcare, Scottsdale, Arizona","institution_ids":["https://openalex.org/I4210130412"]},{"raw_affiliation_string":"3Imaging Endpoints, Scottsdale, Arizona","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060435181","display_name":"Natarajan Raghunand","orcid":"https://orcid.org/0000-0002-8893-7687","observed_orcids":["https://orcid.org/0000-0002-8893-7687"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Natarajan Raghunand","raw_affiliation_strings":["4Moffitt Cancer Center, Tampa, Florida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Moffitt Cancer Center, Tampa, Florida","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055462512","display_name":"Jasgit C. Sachdev","orcid":"https://orcid.org/0000-0002-4408-7617","observed_orcids":["https://orcid.org/0000-0002-4408-7617"]},"institutions":[{"id":"https://openalex.org/I4210130412","display_name":"HonorHealth","ror":"https://ror.org/03szbwj17","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210130412"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jasgit C. Sachdev","raw_affiliation_strings":["1Virginia G Piper Cancer Center, Honor Healthcare, Scottsdale, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Virginia G Piper Cancer Center, Honor Healthcare, Scottsdale, Arizona","institution_ids":["https://openalex.org/I4210130412"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034141512","display_name":"Ronald G. Newbold","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130412","display_name":"HonorHealth","ror":"https://ror.org/03szbwj17","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210130412"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronald G. Newbold","raw_affiliation_strings":["1Virginia G Piper Cancer Center, Honor Healthcare, Scottsdale, Arizona","3Imaging Endpoints, Scottsdale, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Virginia G Piper Cancer Center, Honor Healthcare, Scottsdale, Arizona","institution_ids":["https://openalex.org/I4210130412"]},{"raw_affiliation_string":"3Imaging Endpoints, Scottsdale, Arizona","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003323232","display_name":"Gayle Jameson","orcid":"https://orcid.org/0000-0003-0987-5965","observed_orcids":["https://orcid.org/0000-0003-0987-5965"]},"institutions":[{"id":"https://openalex.org/I4210130412","display_name":"HonorHealth","ror":"https://ror.org/03szbwj17","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210130412"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gayle Jameson","raw_affiliation_strings":["1Virginia G Piper Cancer Center, Honor Healthcare, Scottsdale, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Virginia G Piper Cancer Center, Honor Healthcare, Scottsdale, Arizona","institution_ids":["https://openalex.org/I4210130412"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062284417","display_name":"Gerald J. Fetterly","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gerald J. Fetterly","raw_affiliation_strings":["5Roswell Park Cancer Institute, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Roswell Park Cancer Institute, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088994089","display_name":"Joshua D. Prey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joshua Prey","raw_affiliation_strings":["5Roswell Park Cancer Institute, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Roswell Park Cancer Institute, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054166052","display_name":"Stephan G. Klinz","orcid":"https://orcid.org/0000-0001-7354-3346","observed_orcids":["https://orcid.org/0000-0001-7354-3346"]},"institutions":[{"id":"https://openalex.org/I4210124791","display_name":"Merrimack Pharmaceuticals (United States)","ror":"https://ror.org/034dw6775","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124791"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Stephan G. Klinz","raw_affiliation_strings":["6Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210124791"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jaeyeon Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124791","display_name":"Merrimack Pharmaceuticals (United States)","ror":"https://ror.org/034dw6775","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124791"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jaeyeon Kim","raw_affiliation_strings":["6Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210124791"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066009774","display_name":"Jason E. Cain","orcid":"https://orcid.org/0000-0003-3987-5894","observed_orcids":["https://orcid.org/0000-0003-3987-5894"]},"institutions":[{"id":"https://openalex.org/I4210124791","display_name":"Merrimack Pharmaceuticals (United States)","ror":"https://ror.org/034dw6775","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124791"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason Cain","raw_affiliation_strings":["6Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210124791"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035474346","display_name":"Bart S. Hendriks","orcid":"https://orcid.org/0000-0002-4219-4945","observed_orcids":["https://orcid.org/0000-0002-4219-4945"]},"institutions":[{"id":"https://openalex.org/I4210124791","display_name":"Merrimack Pharmaceuticals (United States)","ror":"https://ror.org/034dw6775","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124791"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bart S. Hendriks","raw_affiliation_strings":["6Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210124791"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008160506","display_name":"Daryl C. Drummond","orcid":"https://orcid.org/0000-0001-6803-8863","observed_orcids":["https://orcid.org/0000-0001-6803-8863"]},"institutions":[{"id":"https://openalex.org/I4210124791","display_name":"Merrimack Pharmaceuticals (United States)","ror":"https://ror.org/034dw6775","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124791"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daryl C. Drummond","raw_affiliation_strings":["6Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210124791"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048957048","display_name":"Eliel Bayever","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124791","display_name":"Merrimack Pharmaceuticals (United States)","ror":"https://ror.org/034dw6775","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124791"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eliel Bayever","raw_affiliation_strings":["6Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210124791"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109881019","display_name":"Jonathan B. Fitzgerald","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124791","display_name":"Merrimack Pharmaceuticals (United States)","ror":"https://ror.org/034dw6775","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124791"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan B. Fitzgerald","raw_affiliation_strings":["6Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210124791"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5054166052","https://openalex.org/A5113733729"],"corresponding_institution_ids":["https://openalex.org/I1284308235","https://openalex.org/I4210124791","https://openalex.org/I4210130412"],"apc_list":null,"apc_paid":null,"fwci":8.2807,"has_fulltext":false,"cited_by_count":185,"citation_normalized_percentile":{"value":0.99173241,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"23","issue":"14","first_page":"3638","last_page":"3648"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.6401000022888184,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.6401000022888184,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11885","display_name":"MRI in cancer diagnosis","score":0.20170000195503235,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12405","display_name":"Characterization and Applications of Magnetic Nanoparticles","score":0.0414000004529953,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ferumoxytol","display_name":"ferumoxytol","score":0.9769999980926514},{"id":"https://openalex.org/keywords/iron-nanoparticles","display_name":"iron nanoparticles","score":0.6140000224113464},{"id":"https://openalex.org/keywords/magnetic-resonance-imaging","display_name":"magnetic resonance imaging","score":0.30799999833106995},{"id":"https://openalex.org/keywords/nanoliposomal-irinotecan","display_name":"nanoliposomal irinotecan","score":0.9660000205039978},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.9259999990463257},{"id":"https://openalex.org/keywords/drug-response-prediction","display_name":"drug response prediction","score":0.5830000042915344},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.734000027179718},{"id":"https://openalex.org/keywords/pharmacokinetic-modeling","display_name":"pharmacokinetic modeling","score":0.6959999799728394}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8744032382965088},{"id":"https://openalex.org/C2909801847","wikidata":"https://www.wikidata.org/wiki/Q411235","display_name":"Ferumoxytol","level":3,"score":0.7013534307479858},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.5919137597084045},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.4874587059020996},{"id":"https://openalex.org/C2781156865","wikidata":"https://www.wikidata.org/wiki/Q827023","display_name":"Lesion","level":2,"score":0.46341603994369507},{"id":"https://openalex.org/C70816921","wikidata":"https://www.wikidata.org/wiki/Q258852","display_name":"Effective diffusion coefficient","level":3,"score":0.4547043442726135},{"id":"https://openalex.org/C143409427","wikidata":"https://www.wikidata.org/wiki/Q161238","display_name":"Magnetic resonance imaging","level":2,"score":0.421206533908844},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3777484595775604},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.2691730260848999},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2589312791824341},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.19323286414146423},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.11750149726867676}],"mesh":[{"descriptor_ui":"D000077146","descriptor_name":"Irinotecan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008081","descriptor_name":"Liposomes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008081","descriptor_name":"Liposomes","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D008279","descriptor_name":"Magnetic Resonance Imaging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052203","descriptor_name":"Ferrosoferric Oxide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D052203","descriptor_name":"Ferrosoferric Oxide","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D052203","descriptor_name":"Ferrosoferric Oxide","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.ccr-16-1990","doi":"https://doi.org/10.1158/1078-0432.ccr-16-1990","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-16-1990","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:28159813","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28159813","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G9000888465","display_name":"Roswell Park Cancer Center Support Grant","funder_award_id":"P30CA016056","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W1874889006","https://openalex.org/W1928083400","https://openalex.org/W1939928680","https://openalex.org/W1972756117","https://openalex.org/W1985858988","https://openalex.org/W1988603610","https://openalex.org/W1994399615","https://openalex.org/W2002516695","https://openalex.org/W2014291850","https://openalex.org/W2020979302","https://openalex.org/W2021206870","https://openalex.org/W2041354095","https://openalex.org/W2043809826","https://openalex.org/W2065109272","https://openalex.org/W2066374585","https://openalex.org/W2066861571","https://openalex.org/W2069746446","https://openalex.org/W2070252009","https://openalex.org/W2078097297","https://openalex.org/W2083784395","https://openalex.org/W2085440855","https://openalex.org/W2093100973","https://openalex.org/W2094066733","https://openalex.org/W2099374439","https://openalex.org/W2105939926","https://openalex.org/W2115776299","https://openalex.org/W2117359382","https://openalex.org/W2118167053","https://openalex.org/W2120264642","https://openalex.org/W2127670903","https://openalex.org/W2134561310","https://openalex.org/W2144020449","https://openalex.org/W2146274229","https://openalex.org/W2146757262","https://openalex.org/W2153771870","https://openalex.org/W2156969927","https://openalex.org/W2159759141","https://openalex.org/W2160843021","https://openalex.org/W2166885734","https://openalex.org/W2173359203","https://openalex.org/W2187917981","https://openalex.org/W2317019069","https://openalex.org/W2319443619","https://openalex.org/W2523119479","https://openalex.org/W2561995968","https://openalex.org/W2618474022","https://openalex.org/W4241932028"],"related_works":["https://openalex.org/W2405639273","https://openalex.org/W1565366196","https://openalex.org/W2048777642","https://openalex.org/W4385554503","https://openalex.org/W2066374585","https://openalex.org/W2048816829","https://openalex.org/W4385545308","https://openalex.org/W4319057676","https://openalex.org/W2183715633","https://openalex.org/W6939730787"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"To":[2],"determine":[3],"whether":[4],"deposition":[5],"characteristics":[6],"of":[7,119,126,161],"ferumoxytol":[8],"(FMX)":[9],"iron":[10],"nanoparticles":[11],"in":[12,60,110,117,173,212,232,259],"tumors,":[13],"identified":[14],"by":[15,67,108,176],"quantitative":[16],"MRI,":[17],"may":[18,248],"predict":[19],"tumor":[20,65,94,115,233,246],"lesion":[21,174,240],"response":[22,258],"to":[23,56,133,158,242],"nanoliposomal":[24],"irinotecan":[25],"(nal-IRI).":[26],"Experimental":[27],"Design:":[28],"Eligible":[29],"patients":[30,260],"with":[31,69,136,171,203,215,261],"previously":[32],"treated":[33],"solid":[34,262],"tumors":[35],"had":[36],"FMX-MRI":[37,109,138],"scans":[38],"before":[39],"and":[40,44,64,114,142,189,235,244,253],"following":[41],"(1,":[42],"24,":[43],"72":[45,96,151,207],"hours)":[46],"FMX":[47,58,99,134,146,154,230,243],"injection.":[48],"After":[49],"MRI":[50],"acquisition,":[51],"R2*":[52],"signal":[53],"was":[54,201],"used":[55],"calculate":[57],"levels":[59,105,155,205,211,231],"plasma,":[61,111],"reference":[62,112],"tissue,":[63],"lesions":[66,95,116,164,213,234],"comparison":[68],"a":[70,127,250],"phantom-based":[71],"standard":[72],"curve.":[73],"Patients":[74],"then":[75],"received":[76],"nal-IRI":[77,236,257],"(70":[78],"mg/m2":[79],"free":[80],"base":[81],"strength)":[82],"biweekly":[83],"until":[84],"progression.":[85],"Two":[86],"percutaneous":[87],"core":[88],"biopsies":[89],"were":[90,106,168],"collected":[91],"from":[92,165],"selected":[93],"hours":[97,195],"after":[98],"or":[100],"nal-IRI.":[101],"Results:":[102],"Iron":[103],"particle":[104],"quantified":[107],"tissues,":[113],"13":[118],"15":[120],"eligible":[121],"patients.":[122],"On":[123],"the":[124],"basis":[125],"mechanistic":[128],"pharmacokinetic":[129],"model,":[130],"tissue":[131,147],"permeability":[132,241],"correlated":[135,214],"early":[137,180],"signals":[139],"at":[140,150,179,186,193,206],"1":[141,187],"24":[143,194],"hours,":[144],"while":[145],"binding":[148],"contributed":[149],"hours.":[152,208],"Higher":[153],"(ranked":[156],"relative":[157],"median":[159],"value":[160],"multiple":[162],"evaluable":[163],"9":[166],"patients)":[167],"significantly":[169],"associated":[170],"reduction":[172],"size":[175],"RECIST":[177],"v1.1":[178],"time":[181,217],"points":[182],"(P":[183],"<":[184,191],"0.001":[185],"hour":[188],"P":[190,224],"0.003":[192],"FMX-MRI,":[196],"one-way":[197],"ANOVA).":[198],"No":[199],"association":[200],"observed":[202],"post-FMX":[204],"Irinotecan":[209],"drug":[210],"patient's":[216],"on":[218],"treatment":[219],"(Spearman":[220],"\u03c1":[221],"=":[222,225],"0.7824;":[223],"0.0016).":[226],"Conclusions:":[227],"Correlation":[228],"between":[229],"activity":[237],"suggests":[238],"that":[239],"subsequent":[245],"uptake":[247],"be":[249],"useful":[251],"noninvasive":[252],"predictive":[254],"biomarker":[255],"for":[256],"tumors.":[263],"Clin":[264],"Cancer":[265],"Res;":[266],"23(14);":[267],"3638\u201348.":[268],"\u00a92017":[269],"AACR.":[270]},"counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":16},{"year":2023,"cited_by_count":20},{"year":2022,"cited_by_count":22},{"year":2021,"cited_by_count":17},{"year":2020,"cited_by_count":32},{"year":2019,"cited_by_count":29},{"year":2018,"cited_by_count":23},{"year":2017,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-02-10T00:00:00"}